Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy.
Schcolnik-Cabrera A, Chávez-Blanco A, Domínguez-Gómez G, Taja-Chayeb L, Morales-Barcenas R, Trejo-Becerril C, Perez-Cardenas E, Gonzalez-Fierro A, Dueñas-González A. Schcolnik-Cabrera A, et al. Expert Opin Investig Drugs. 2018 May;27(5):475-489. doi: 10.1080/13543784.2018.1471132. Epub 2018 May 10. Expert Opin Investig Drugs. 2018. PMID: 29723075 Review.
Circulating nucleosomes and response to chemotherapy: an in vitro, in vivo and clinical study on cervical cancer patients.
Trejo-Becerril C, Pérez-Cárdenas E, Treviño-Cuevas H, Taja-Chayeb L, García-López P, Segura-Pacheco B, Chávez-Blanco A, Lizano-Soberon M, González-Fierro A, Mariscal I, Wegman-Ostrosky T, Dueñas-González A. Trejo-Becerril C, et al. Int J Cancer. 2003 May 10;104(6):663-8. doi: 10.1002/ijc.11003. Int J Cancer. 2003. PMID: 12640671 Free article.
HER2 expression in cervical cancer as a potential therapeutic target.
Chavez-Blanco A, Perez-Sanchez V, Gonzalez-Fierro A, Vela-Chavez T, Candelaria M, Cetina L, Vidal S, Dueñas-Gonzalez A. Chavez-Blanco A, et al. BMC Cancer. 2004 Sep 1;4:59. doi: 10.1186/1471-2407-4-59. BMC Cancer. 2004. PMID: 15341668 Free PMC article.
Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study.
Chavez-Blanco A, Segura-Pacheco B, Perez-Cardenas E, Taja-Chayeb L, Cetina L, Candelaria M, Cantu D, Gonzalez-Fierro A, Garcia-Lopez P, Zambrano P, Perez-Plasencia C, Cabrera G, Trejo-Becerril C, Angeles E, Duenas-Gonzalez A. Chavez-Blanco A, et al. Mol Cancer. 2005 Jul 7;4(1):22. doi: 10.1186/1476-4598-4-22. Mol Cancer. 2005. PMID: 16001982 Free PMC article. Clinical Trial.
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines.
Chavez-Blanco A, Perez-Plasencia C, Perez-Cardenas E, Carrasco-Legleu C, Rangel-Lopez E, Segura-Pacheco B, Taja-Chayeb L, Trejo-Becerril C, Gonzalez-Fierro A, Candelaria M, Cabrera G, Duenas-Gonzalez A. Chavez-Blanco A, et al. Cancer Cell Int. 2006 Jan 31;6:2. doi: 10.1186/1475-2867-6-2. Cancer Cell Int. 2006. PMID: 16448574 Free PMC article.
A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer.
Arce C, Pérez-Plasencia C, González-Fierro A, de la Cruz-Hernández E, Revilla-Vázquez A, Chávez-Blanco A, Trejo-Becerril C, Pérez-Cárdenas E, Taja-Chayeb L, Bargallo E, Villarreal P, Ramírez T, Vela T, Candelaria M, Camargo MF, Robles E, Dueñas-González A. Arce C, et al. PLoS One. 2006 Dec 20;1(1):e98. doi: 10.1371/journal.pone.0000098. PLoS One. 2006. PMID: 17183730 Free PMC article. Clinical Trial.
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors.
Candelaria M, Gallardo-Rincón D, Arce C, Cetina L, Aguilar-Ponce JL, Arrieta O, González-Fierro A, Chávez-Blanco A, de la Cruz-Hernández E, Camargo MF, Trejo-Becerril C, Pérez-Cárdenas E, Pérez-Plasencia C, Taja-Chayeb L, Wegman-Ostrosky T, Revilla-Vazquez A, Dueñas-González A. Candelaria M, et al. Ann Oncol. 2007 Sep;18(9):1529-38. doi: 10.1093/annonc/mdm204. Ann Oncol. 2007. PMID: 17761710 Free article. Clinical Trial.
The prince and the pauper. A tale of anticancer targeted agents.
Dueñas-González A, García-López P, Herrera LA, Medina-Franco JL, González-Fierro A, Candelaria M. Dueñas-González A, et al. Mol Cancer. 2008 Oct 23;7:82. doi: 10.1186/1476-4598-7-82. Mol Cancer. 2008. PMID: 18947424 Free PMC article. Review.
37 results